We have sent an OTP to your contact. Please enter it below to verify.
Alert
Your message here...
Your notification message here...
For any questions or assistance regarding Customer Support, Sales Inquiries, Technical Support, or General Inquiries, our AI-powered team is here to help!
Upskill and
Grow
with AI
Career Tools and Resources
Career Tools and Resources
Biogenetic Drugs is a biotechnology firm specializing in the development of genetic therapies and pharmaceutical solutions aimed at treating various genetic disorders.
BioGenex designs, develops, and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of our eFISHency integrated workflow solution for FISH laboratories and miRNA system for characterization of cancer of unknown primary (CUP) and for undifferentiated tumors is a game changer that has no rival in the industry. Our fully automated molecular pathology work stations are the most advanced system globally. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest systems for life science research and diagnostics. With a team of accomplished technical, business and customer support professionals, BioGenex strives to reach the pinnacle of the global molecular medicine industry by offering cost-effective solutions for life sciences research and personalized medicine. Additionally, the partnership of BioGenex with top-notch universities, hospitals, and the pharmaceutical and biotechnology industry drives its innovative research and product development activities. The company is also known for its pre- and post-sales customer support that complements the high quality products and solutions offered by the firm.
Biogenomics is a science-driven, vertically integrated pharmaceutical company specializing in treatments for diabetes and oncology. Backed by Oman Investment Authority and guided by a team of distinguished scientists, business leaders, and experts in molecular biology, microbiology, and protein engineering, Biogenomics has in a short span of time has developed a wide portfolio of biosimilars and biotech products. As an industry pioneer, Biogenomics became the first company in India to successfully launch a biosimilar of Insulin Aspart. With a robust pipeline, the company has several additional products awaiting approval. Committed to enhancing patient outcomes globally, Biogenomics has an active clinical development program focused on advancing chemical entities and biologics for the treatment of diabetes, cancer, and other critical therapeutic areas. As a young, fast-growing biopharmaceutical firm, Biogenomics is on a path to delivering excellence in healthcare. Our mission is to enrich lives by providing high-quality, affordable drugs, ensuring patient access to expensive specialty pharmaceuticals and biologic treatments. With two new additional manufacturing facilities coming up in India and Oman, Biogenomics is poised for significant global expansion. Beginning filings in 2025, the company plans to extend its reach into North America, Europe, and other key markets, further solidifying its international presence.
bioID Technologies specializes in biometric authentication solutions, offering advanced identity verification technologies to enhance security in various applications.
BioKlone Biotech specializes in the development and production of innovative biotechnological solutions for health and agriculture.
Biologique Foods specializes in the production and distribution of organic food products aimed at promoting health and sustainability. Their focus is on providing high-quality, GMO-free ingredients sourced from organic farms.
Biomatrix Healthcare is dedicated to providing innovative solutions in the healthcare sector, specializing in regenerative medicine and advanced biomaterials.